Award notice, first published as presolicitation
Pharm Manuf/Distr Div - FSA
SPE2D2-24-R-0015
Defense Logistics Agency, DLA Troop Support. Medicinal and Botanical Manufacturing.
Awarded
$64,576,637.85 on the award notice, December 11, 2025, contract SPE2D2-26-D-0002
Description
As published on SAM.gov with the award notice of December 11, 2025.
National Contract Award to AvKARE, LLC. (SPE2D2-26-D-0002) for Telmisartan Tablets originally solicited under SPE2D2-24-R-0015.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Avkare LLC
- UEI
- SFPGXE6XPS93
- CAGE
- 4QGW8
- Vendor location
- Pulaski, TN
- Contract
- SPE2D226D0002
- Obligated
- $0.00, potential $64,576,638
- Actions
- 1 between December 11, 2025 and December 11, 2025
- Competition
- Full and Open Competition, 9 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 4610127045!
- Match
- award number SPE2D226D0002 equals the contract number; same awarding office SPE2D2 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 23, 2024
Presolicitation
Telmisartan Tablets
SAM.gov, notice 2a836ea283424ef7becf73f05620ea18
December 11, 2025
Award notice, originally solicitation
Telmisartan Tablets
Awarded to AVKARE LLC Pulaski for $64,576,638. SAM.gov, notice 5334df7711b44579ae1dd7022ff6b624
December 11, 2025
Award notice
Awarded to Avkare LLC for $64,576,638. SAM.gov, notice 7c2a338c767646a7bdf1191508da0316
Points of contact
- Catherine Gilbert4457378868Catherine.Gilbert@dla.mil
Also open from this buyer
- Febuxostat TabletsSolicitationNAICS 325412SPE2D2-26-R-0012Closes in 7 daysSep 24
- Progesterone CapsulesSolicitationNAICS 325412SPE2D2-26-R-0015Closes in 15 daysOct 2